LMO2 is an intrinsically disordered transcription factor activated in T cell leukaemia that is difficult to target. It forms part of a multiprotein complex that has bipartite DNA binding through ...

Detailed price information for Sonnet Biotherapeutics Holdings Inc (SONN-Q) from The Globe and Mail including charting and trades.

Dr. Jacob A. Sands shares how antibody-drug conjugates, such as Datroway, work to selectively target and destroy tumor cells ...

Recombinant antibodies and therapeutic proteins—like monoclonal antibodies, bispecific antibodies, and Fc fusion proteins—are ...

Building on bispecific antibodies, four of which have been approved by the FDA to treat relapsed/refractory multiple myeloma, ...

T cells and/or bispecific antibody (BsAb) has been established and become a promising treatment strategy for ...

In the ERC project HelixMold, a team from TU Graz developed a method for the computer-based design of artificial proteins, ...

Key Laboratory of Agricultural Biosafety and Green Production of Upper Yangtze River (Ministry of Education), College of Horticulture and Landscape Architecture, Southwest University, Chongqing, China ...